Table 1.
Patient and donor characteristics
| Age | Recipient | 51 |
| Donor | 22 | |
| Cold ischemia time | 8.7 h | |
| MELD | 23 | |
| Male | 67% | |
| Race | Black | 13% |
| White | 56% | |
| Other | 31% | |
| Liver diagnosis | Hepatitis C | 36% |
| Alcoholic liver disease | 15% | |
| NASH/CC/metabolic | 15% | |
| Retransplant | 10% | |
| Hepatitis B | 5% | |
| PSC/AIH/PBC | 4% | |
| Other | 15% | |
| Hepatocellular carcinoma | 12% | |
| Immunosupression 3 months | Tacrolimus | 59% |
| Cyclosporine | 37% | |
| Steroids | 96% | |
| Renal indications for Transplant | Diabetic or hypertensive nephropathy | 26% |
| Polycystic kidney disease | 12% | |
| Glomerulonephritis | 14% | |
| HRS/ATN | 11% | |
| Retransplant | 7% | |
| CNI toxicity | 6% | |
| Oxalosis | 5% | |
| Amyloid/IN/reflux | 5% | |
| IgA nephropathy | 2% | |
| Other | 12% |
MELD = Model for End-Stage Liver Disease; NASH = nonalcoholic steatohepatitis; CC = cryptogenic cirrhosis; PSC, primary sclerosing cholangitis; AIH, autoimmune hepatitis; PBC = primary biliary cirrhosis; HRS = hepatorenal syndrome; ATN = acute tubular necrosis; IN = interstitial